RTS names Richard Carpenter mid-Atlantic sales manager

RTS Life Science, a UK-based supplier of automated sample management and drug delivery testing systems, has appointed Richard Carpenter as mid-Atlantic sales manager.

RTS Life Science, a UK-based supplier of automated sample management and drug delivery testing systems, has appointed Richard Carpenter as mid-Atlantic sales manager. Carpenter has extensive experience in the scientific instrument market and expands the US field-based sales team.

Prior to joining RTS, Carpenter worked for LabCyte and Tecan, where he became an expert in robotics and liquid handling systems.




You may also like

Manufacturing

Software upgrade for RTS Tube Auditor

Improves screening quality, reduces costs and saves time
Regulatory

New NICE thresholds: good news for rare disease drugs but process remains complex

Recent changes introduced by NICE will ultimately see more ultra-rare disease drugs get to market, but Dan Williams, CEO at SynaptixBio, says the process remains challenging
Manufacturing

Preserve and protect your cleanroom with a Guardtech Group Cleanroom Service Plan

Suffolk-based construction experts offering elite packages to ensure all service, maintenance and decontamination needs are taken care of
Manufacturing

Balancing innovation and accessibility in amino acid testing

Butterworth Laboratories expands analytical capabilities to support compliance with Ph. Eur. standards
Manufacturing

Almac expands bioavailability capabilities to address a critical need in drug development

Almac Group has completed a multimillion-pound expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Quality management during manufacturing changes: part I

Change is a universal constant and continues to accelerate in the realms of pharmaceutical, medical device and in-vitro diagnostic manufacturers who face ever-increasing pressure to optimise costs while maintaining high product quality and patient safety standards
Regulatory

Oncolytics Biotech announces positive clinical data for metastatic colorectal cancer trial

The latest results could accelerate the company's path to registration after the FDA's Breakthrough Therapy designations created momentum for companies advancing pioneering oncology platforms
Subscribe now